Caplin Point Laboratories (NSE:CAPLIPOINT) Institutional Ownership: 7.66% (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CAPLIPOINT Caplin Point Laboratories Ltd NSE:CAPLIPOINT
91 GF Score
Price ₹2,480.60
GF Value ₹2,093.91
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Caplin Point Laboratories Institutional Ownership?

Caplin Point Laboratories NSE:CAPLIPOINT -4.88% 91 Institutional Ownership is 7.66% as of Jul. 23, 2026. GuruFocus rates NSE:CAPLIPOINT with a GF Score™ of 91/100 and a GF Value™ of ₹2,093.91 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Caplin Point Laboratories's institutional ownership is 7.66%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Caplin Point Laboratories's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Caplin Point Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.

Caplin Point Laboratories Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Caplin Point Laboratories's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caplin Point Laboratories Institutional Ownership Chart

Caplin Point Laboratories Historical Data

The historical data trend for Caplin Point Laboratories can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 8.15 8.17 8.31 8.37 8.40 8.45 8.45 7.68 7.68 7.66
NSE:CAPLIPOINT
91GF Score
Caplin Point Laboratories Ltd NSE:CAPLIPOINT
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caplin Point Laboratories Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 7.66% mean?
Caplin Point Laboratories (NSE:CAPLIPOINT) has a Institutional Ownership of 7.66% as of Jul. 23, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Caplin Point Laboratories and its competitors.
Is Caplin Point Laboratories' Institutional Ownership too high?
Caplin Point Laboratories' current Institutional Ownership is 7.66%. Overall, Caplin Point Laboratories has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Caplin Point Laboratories' Institutional Ownership compare to ZTS and UTHR?
Caplin Point Laboratories' Institutional Ownership of 7.66% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Caplin Point Laboratories and its competitors. Caplin Point Laboratories's current Institutional Ownership is 7.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caplin Point Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Caplin Point Laboratories (NSE:CAPLIPOINT) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,093.91, compared to a current price of ₹2,480.60 — trading 18.5% above its estimated fair value. The current Institutional Ownership is 7.66%. Caplin Point Laboratories' overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Caplin Point Laboratories (NSE:CAPLIPOINT), the current Institutional Ownership is 7.66% as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Caplin Point Laboratories (NSE:CAPLIPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Caplin Point Laboratories stock appears to be overvalued. The current stock price of ₹2,480.60 is trading 18.5% above its estimated GF Value™ of ₹2,093.91. GuruFocus considers Caplin Point Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:CAPLIPOINT:

  • Institutional Ownership: 7.66%
  • GF Value™: ₹2,093.91 vs. price of ₹2,480.60 (18.5% above fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAPLIPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Caplin Point Laboratories Business Description

Other Exchanges 524742:India
Address Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
91GF Score

Get the complete analysis for NSE:CAPLIPOINT

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,480.60
Price
₹2,093.91
GF Value